[Federal Register Volume 79, Number 134 (Monday, July 14, 2014)]
[Notices]
[Page 40780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-16318]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Meridian Medical 
Technologies

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Meridian Medical Technologies applied to be registered as an 
importer of a certain basic class of narcotic controlled substance. The 
DEA grants Meridian Medical Technologies registration as an importer of 
this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated April 21, 2014, and 
published in the Federal Register on April 28, 2014, 79 FR 23374, 
Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri 
63144, applied to be registered as an importer of a certain basic class 
of controlled substance. No comments or objections were submitted for 
this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Meridian Medical Technologies to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of morphine (9300), a basic class of 
narcotic controlled substance listed in schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world. The company has been asked to ensure that its product, which is 
sold to European customers, meets the standards established by the 
European Pharmacopeia, administered by the Directorate for the Quality 
of Medicines (EDQM). In order to ensure that its product will meet 
European specifications, the company seeks to import morphine supplied 
by EDQM for use as reference standards.
    This is the sole purpose for which the company will be authorized 
by the DEA to import morphine.

    Dated: July 7, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-16318 Filed 7-11-14; 8:45 am]
BILLING CODE 4410-09-P